Yohei Norimatsu

Cystic Fibrosis Transmembrane Conductance Regulator: Using Differential Reactivity toward Channel-Permeant and Channel-Impermeant Thiol-Reactive Probes To Test a Molecular Model for the Pore

Christopher W. Alexander, Anthony Ivetac, Xuehong Liu et al. · Biochemistry · 2009 · 70 citations · Full text

Natural Sciences, Biochemistry, Molecular Biology +17

Cystic Fibrosis Transmembrane Conductance Regulator: A Molecular Model Defines the Architecture of the Anion Conduction Path and Locates a “Bottleneck” in the Pore

Yohei Norimatsu, Anthony Ivetac, Christopher W. Alexander et al. · Biochemistry · 2012 · 54 citations · Full text

Natural Sciences, Biophysics, Molecular Biology +17

Locating a Plausible Binding Site for an Open-Channel Blocker, GlyH-101, in the Pore of the Cystic Fibrosis Transmembrane Conductance Regulator

Yohei Norimatsu, Anthony Ivetac, Christopher W. Alexander et al. · Molecular Pharmacology · 2012 · 44 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Lubiprostone activates CFTR, but not ClC-2, via the prostaglandin receptor (EP4)

Yohei Norimatsu, Aurelia R. Moran, Kelvin D. MacDonald · Biochemical and Biophysical Research Communications · 2012 · 41 citations

Life Sciences, Cell Biology, Pharmacology +11

Exploring the Determinants of Trace Amine-Associated Receptor 1’s Functional Selectivity for the Stereoisomers of Amphetamine and Methamphetamine

Edmund A. Reese, Yohei Norimatsu, Madeline Grandy et al. · Journal of Medicinal Chemistry · 2013 · 38 citations · Full text

Medicine, Neuroscience, Pharmacology +17